Idiopathic Pulmonary Fibrosis (IPF)
While FEV and FVC1 continue to be the primary way of measuring disease progression in IPF patients, more emphasis from regulators continues to be placed on measuring how patients feel, function and survive5. Cough monitoring in IPF has emerged as a promising outcome measure that can reveal direct, objective insight into patients’ lived experiences and offer drug developers a consistent and reliable endpoint.
Accurately measure cough and crackles in IPF patients from anywhere, anytime
- Clinically validated accuracy, with equivalent performance to Littman 3200 stethoscope.
- Continuous monitoring of cough and lung sounds to offer quantitative data on respiratory symptoms over time.
- Patient-friendly, reduces the burden on patients while improving clinician efficiency.
Download the Strados Publication
Objective monitoring detects more patients with coughs than patient self-reporting
For Healthcare
Improve surveillance of IPF patients with real-time monitoring of symptoms
For Research Studies
Gain greater, objective insight into IPF treatment response in clinical trials
Expert Overread Process
- Our team of trained respiratory therapists and labelers review subject lung sound recordings to meet regulatory and clinical requirements for data accuracy.
- Machine learning algorithms* have been trained based on validated cough and lung sound events and performance tested to meet customer requirements.
- Algorithms* can be used independently or to assist in the overread process.
*Machine learning algorithms not FDA-cleared
Cough
Wheeze
Crackles
Clinical Validation
What data does the device collect in IPF patients?
The RESP® Biosensor sits on the patient’s chest wall and passively records patient’s lung sounds including cough, wheeze and crackles. The device also collects motion data to capture respiratory rate*, heart rate*, activity levels*, and body positioning*.
*Measurement not FDA-cleared
How do you know that the RESP® Biosensor is accurate?
The RESP Biosensor has received two FDA 510(k) clearances to record lung sounds. In order to receive FDA clearance, Strados Labs provided test results that demonstrated audio performance that is substantially equivalent to commercially available electronic stethoscopes.
How is the device adhered to patients’ chests? Does it cause any discomfort?
The non-invasive RESP® Biosensor is placed over the skin and adhered via Tegaderm–acrylic based adhesive. Patients often forget the device is on when wearing and can go on with their daily routines.
Let’s Connect
Explore Using Our Technology in Your Practice or Upcoming Study
References
- Lee et al. (2022). Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry. Chest, 162(3), 603–613. https://doi.org/10.1016/j.chest.2022.03.025
- Cox, I. A., Borchers Arriagada, N., de Graaff, B., Corte, T. J., Glaspole, I., Lartey, S., Walters, E. H., & Palmer, A. J. (2020). Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. European respiratory review : an official journal of the European Respiratory Society, 29(158), 200154. https://doi.org/10.1183/16000617.0154-2020
- Wu et al. (2024). Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine, 209(9), 1165–1167. https://doi.org/10.1164/rccm.202311-2169LE
- Wijsenbeek, et al. (2023). Home monitoring in interstitial lung diseases. The Lancet. Respiratory medicine, 11(1), 97–110. https://doi.org/10.1016/S2213-2600(22)00228-4
- Raghu et al. (2024). Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. American journal of respiratory and critical care medicine. 209. 10.1164/rccm.202312-2213SO; Wijsenbeek, et al. (2023). Home monitoring in interstitial lung diseases. The Lancet. Respiratory medicine, 11(1), 97–110. https://doi.org/10.1016/S2213-2600(22)00228-4
- Moran-Mendoza, O., Ritchie, T., & Aldhaheri, S. (2021). Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study. BMJ open respiratory research, 8(1), e000815. https://doi.org/10.1136/bmjresp-2020-000815
- Sgalla, G., Walsh, S. L. F., Sverzellati, N., Fletcher, S., Cerri, S., Dimitrov, B., Nikolic, D., Barney, A., Pancaldi, F., Larcher, L., Luppi, F., Jones, M. G., Davies, D., & Richeldi, L. (2018). “Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease. BMC pulmonary medicine, 18(1), 103. https://doi.org/10.1186/s12890-018-0670-0